Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kinichi Imai is active.

Publication


Featured researches published by Kinichi Imai.


Experimental Parasitology | 1984

Eimeria tenella, E. necatrix, E. acervulina, and E. maxima: anticoccidial activity of 1,6-dihydro-6-oxo-2-pyrazinecarboxylic acid 4-oxide

Toshimi Matsuno; Nobuo Kobayashi; Fumio Hariguchi; Toshiyuki Yamazaki; Kinichi Imai; Hiroshi Onaga

The anticoccidial activity of an orotic acid analog, 1,6-dihydro-6-oxo-2-pyrazinecarboxylic acid 4-oxide (carboxyemimycin), was tested in battery experiments, utilizing 9-day-old Single-Comb White Leghorn cockerels. Carboxyemimycin, at 125 ppm and more in feed, exhibited marked anticoccidial activities against Eimeria tenella, E. necatrix, E. acervulina, and E. maxima. High doses of carboxyemimycin--up to 1000 ppm--did not cause any reduction in weight gains. The battery and in vitro studies with delayed and restricted medications revealed that carboxyemimycin affected the development of E. tenella in first and second generation schizogony and in gametogony.


Experimental Parasitology | 1986

Eimeria tenella, E. necatrix, E. acervulina, E. maxima, and E. brunetti: Potent anticoccidial activity of an uridine analog, 1-(β-d-ribofuranosyl)-2(1H)-pyrazinone 4-oxide

Nobuo Kobayashi; Toshimi Matsuno; Fumio Hariguchi; Toshiyuki Yamazaki; Kinichi Imai; Hiroshi Onaga; Toshio Ishii

The anticoccidial activity of an uridine analog, 1-(beta-D-ribofuranosyl)-2(1H)-pyrazinone 4-oxide (emimycin riboside), against five species of chicken Eimeria was tested individually in battery experiments. With 16 ppm of the compound in feed, marked anticoccidial activity was obtained against Eimeria tenella, E. necatrix, E. acervulina, E. maxima, and E. brunetti. The last named species was more drug-sensitive than the others--dietary levels of at least 8 ppm of the drug exhibited good protection and eliminated practically all clinical signs. The battery tests with delayed and restricted medications showed that emimycin riboside affected the development of parasites in first and second generation schizogony of the life cycle of E. tenella.


Chemical & Pharmaceutical Bulletin | 1975

Synthesis and coronary vasodilating activity of 2-substituted adenosines.

Ryuji Marumoto; Yoshio Yoshioka; Osamu Miyashita; Shunsuke Shima; Kinichi Imai; Katsuyoshi Kawazoe; Mikio Honjo


Journal of Organic Chemistry | 1969

Phosphorylation. IV. Selective phosphorylation of the primary hydroxyl group in nucleosides

Kinichi Imai; Shoichiro Fujii; Kunio Takanohashi; Yoshiyasu Furukawa; Toru Masuda; Mikio Honjo


Chemical & Pharmaceutical Bulletin | 1966

Synthesis of Purine Nucleosides Using Iodine as Catalyst

Kinichi Imai; Akira Nohara; Mikio Honjo


Chemical & Pharmaceutical Bulletin | 1964

Studies on Nucleic Acid Antagonists. VII. Synthesis and Characterization of 1,4,6-Triazaindenes (5H-Pyrrolo[3,2-d]pyrimidines)

Kinichi Imai


Chemical & Pharmaceutical Bulletin | 1976

Anticoccidials. I. Syntheses and Anticoccidial Activity of 2-Amino-5-aryl-1, 3, 4-oxadiazoles, 5-Alkoxy-3-aryl-1H-1, 2, 4-triazoles, and 3-Aryl-l2-1, 2, 4-triazolin-5-ones

Mitsuhiko Mano; Takuji Seo; Toshimi Matsuno; Kinichi Imai


Chemical & Pharmaceutical Bulletin | 1970

Studies on the Synthesis of Pyrimidine Deoxynucleosides. I. Synthesis of 2', 3'-Dideoxyuridine and 1-(3-Ethylthio-3-deoxy-β-D-xylofuranosyl) uracil

Yoshiyasu Furukawa; Yoshio Yoshioka; Kinichi Imai; Mikio Honjo


Archive | 1971

Method for the production of 2-substituted adenosine derivative

Mikio Honjo; Ryuji Marumoto; Yoshio Yoshioka; Kinichi Imai


Archive | 1966

Method for the production of 5'-ribonucleotide

Kinichi Imai; Mikio Honjo

Collaboration


Dive into the Kinichi Imai's collaboration.

Top Co-Authors

Avatar

Mikio Honjo

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshio Yoshioka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuji Seo

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshiyasu Furukawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Jun Toda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kuniyoshi Tanaka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toshio Sugawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yasushi Sanno

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hisashi Aoki

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge